Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy

Annals of Neurology

Volumn 46, Issue 1, 1999, Pages 79-87

  Van Walderveen, Marianne A A ^a   Barkhof, Frederik ^a   Pouwels, Petra J W ^a   Van Schijndel, Ronald A ^a   Polman, Chris H ^a   Castelijns, Jonas A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOPSY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RELAXATION TIME; STATISTICAL ANALYSIS; TISSUE METABOLISM; TREATMENT OUTCOME; WHITE MATTER;

ADULT; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROTONS; TIME FACTORS;

EID: 0032971730     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199907)46:1<79::AID-ANA12>3.0.CO;2-9     Document Type: Article

References (45)

1. van Walderveen MAA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short TR/short TE (T1-weighted) spin-echo images. Neurology 1995;45:1684-1690
2. Hiehle JF, Grossman RI, Ramer KN, et al. Magnetization transfer effect in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and non-enhanced T1-weighted images. AJNR 1995;16:69-77
3. Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al. Accumulation of hypointense lesions ("black holes") on T1 SE MRI in multiple sclerosis correlates with disease progression. Neurology 1996;47:1469-1476
4. van Walderveen MAA, Kamphorst W, Scheltens Ph, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin echo MRI in MS. Neurology 1998;50:1282-1288
5. Bruck W, Bitsch A, Kolenda H, et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-793
6. Nakano M, Ueda H, Li J, et al. Measurement of regional N-acetylaspartate after transient global ischemia in gerbils with and without ischemic tolerance: an index of neuronal survival. Ann Neurol 1998;44:334-340
7. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989
8. Larsson HBW, Christiansen P, Jensen M, et al. Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn Reson Med 1991;22:23-31
9. Matthews PM, Grancis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 1991;41:1251-1256
10. Arnold DL, Matthews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 1990;14:154-159
11. Arnold DL, Matthews PM, Francis GS, et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992;31:235-241
12. Bruhn H, Frahm J, Merboldt D, et al. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 1992;32:140-150
13. van Hecke P, Marchal G, Johannik K, et al. Human brain proton localized NMR spectroscopy in multiple sclerosis. Magn Reson Med 1991;18:199-206
14. Peters AR, Geelen JAG, den Boer JA, et al. A study of multiple sclerosis patients with magnetic resonance spectroscopic imaging. Multiple Sclerosis 1995;1:25-31
15. 1H MRSI of normal appearing white matter in multiple sclerosis. Multiple Sclerosis 1997;3:231-237
16. Fu L, Matthews PM, De Stefano N, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 1998;121:103-113
17. Schiepers C, van Hecke P, Vandenberghe R, et al. Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis. Multiple Sclerosis 1997;3:8-17
18. Larsson HBW, Frederiksen J, Kjaer L, et al, In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med 1988;7:43-55
19. Miller DH, Johnson G, Tofts PS, et al. Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease. Magn Reson Med 1989;11: 331-336
20. Haughton VM, Zerrin Yetkin F, Rao SM, et al. Quantitative MR in the diagnosis of multiple sclerosis. Magn Reson Med 1992;26:71-78
21. Tofts PS, du Boulay EPG. Towards quantitative measurements of relaxation times and other parameters in the brain. Neuroradiology 1990;32:407-415
22. Lacomis D, Osbakken M, Gross G. Spin-lattice relaxation (T1) times of cerebral white matter in multiple sclerosis. Magn Reson Med 1986;3:194-202
23. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231
24. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911
25. Kamada K, Houkin K, Hida K, et al. Localized proton spectroscopy of focal brain pathology in humans: significant effects of edema on spin-spin relaxation time. Magn Reson Med 1994; 31:537-540
26. Hoult DI, Richards RE. The signal-to-noise ratio of the nuclear magnetic resonance experiment. J Magn Reson 1976;24:71-85
27. Michaelis T, Merboldt KD, Bruhn H, et al. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187: 219-227
28. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30:672-679
29. Pouwels PJW, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 1998;39:53-60
30. Gideon P, Henriksen O. In vivo relaxation of N-acetyl-aspartate, creatine plus phosphocreatine, and choline containing compounds during the course of brain infarction: a proton MRS study. Magn Res Imaging 1992;10:983-988
31. Henriksen O. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS. NMR Biomed 1995;8: 139-148
32. Christiansen P, Schlosser A, Henriksen O. Reduced N-acetyl aspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. Magn Res Imaging 1995;13: 457-462
33. Falini A, Calabrese G, Filippi M, et al. Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. AJNR 1998;19:223-229
34. 1H spectroscopic imaging. Ann Neurol 1994;36:157-165
35. Arnold DL, Riess GT, Matthews PM, et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 1994;36:76-82
36. Frahm J, Bruhn H, Gyngell L, et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo: relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989;11:47-63
37. Christiansen P, Larsson HBW, Henriksen O. Time dependence of N-acetylaspartate and choline containing compounds in multiple sclerosis. Proc Soc Magn Reson Med 1993;1:279 (Abstract)
38. Davies SEC, Newcombe J, Williams SR, et al. High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem 1995;64:742-748
39. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81-91
40. Pouwels PJW, Kruse B, Korenke GC, et al. Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy. Neuropediatrics 1998;29:254-264
41. Barnes D, McDonald WI, Landon DN, Johnson H. The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain 1988;111:83-94
42. Barnes D, Mc Donald WI, Johnson G, et al. The longstanding MS lesion: a quantitative MRI and electron microscopic study. Brain 1991;114:1271-1280
43. van Waesberghe JHTM, van Walderveen MAA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR 1998;19:675-683
44. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338: 278-285
45. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-399